Investing.com - MetLife (NYSE: MET) reported fourth quarter EPS of $1.83, $0.10 worse than the analyst estimate of $1.93. Revenue for the quarter came in at $19.03B versus the consensus estimate of $18.46B.
MetLife's stock price closed at $69.28. It is up 12.18% in the last 3 months and down -4.68% in the last 12 months.
MetLife saw 1 positive EPS revisions and 10 negative EPS revisions in the last 90 days. See MetLife's stock price’s past reactions to earnings here.
According to InvestingPro, MetLife's Financial Health score is "fair performance".
Check out MetLife's recent earnings performance, and MetLife's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar
Is MET truely undervalued?
With MET making headlines, investors are asking: Is it truly valued fairly? InvestingPro's advanced AI algorithms have analyzed MET alongside thousands of other stocks to uncover hidden gems with massive upside. And guess what? MET wasn't at the top of the list.
Unlock ProPicks AI